A carregar...

Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review

PURPOSE: BRCA mutation carriers have an increased risk of developing breast or ovarian cancer. Risk-reducing bilateral salpingo-oophorectomy (RRBSO) is associated with a decrease in risk for tubal and ovarian cancer. Hormone replacement therapy (HRT) may increase breast, ovarian, and endometrial can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer Res Clin Oncol
Main Authors: Huber, D., Seitz, S., Kast, K., Emons, G., Ortmann, O.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164576/
https://ncbi.nlm.nih.gov/pubmed/33885953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-021-03629-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!